Innovative CTO, R&D and Global Ops Leader with 20+ years experience in strategic technology development and delivery of new product opportunities, driving product development and scientific research in industries of Proteomics, Single Cell, Spatial, Multiomics, Next Generation Sequencing (NGS), MEMS/NEMS, forensics, AI and Machine Learning. Known as a change agent and process advocate with deep expertise in the process and program needs of large technology portfolios including complex M&A integration processes. Successfully raised and managed $XXXM+ budgets and driving high-performing global teams to achieve technical, product, and organizational objectives.➢ Launched 50+ products ranging from microfluidic systems and consumables, machine learning and AI software platforms, full DNA sequencing systems, to 3D printing & additive manufacturing-based technologies.➢ Extensive M&A experience in Life Sciences/Biotech Industry, including tech due diligence, strategic contracts, scientific collaborations and IP diligence. As integration leader, highly adept at change management, organizational efficiency and implementing innovation processes for large global R&D organizations.➢ Results-driven leader and cross-discipline manager in the large scale research, design and integration of commercial products within leading-edge biotech, pharma and R&D corporations.➢ Led teams and pipelines, financial toll gating, and resource allocation to maximize portfolios of technology and science innovation towards commercialization and effective product lifecycle management. Expert in managing complex budgets and judging risk and capital efficiency in major projects and programs.➢ Extensive background in global market dynamics, cross-cultural scientific practices and growth-oriented business settings as a frequent speaker, thought leader and team leader. ➢ US and European Citizenship. Inventor on 30+ US and international Patents; lead researcher and author of 10 publications. Active advisor, mentor, and board member for start-ups
Listed skills include Change Management, R&D, Innovation Management, Biotechnology, and 62 others.